These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25377256)

  • 1. Bone marrow cellular cannibalism by medulloblastoma.
    Escamilla V; Franco-Macías E; Calderón-Cabrera C; Rivas E; Morales-Camacho RM; Vargas MT; Bernal R; Pérez-Simón JA
    Am J Hematol; 2015 May; 90(5):466-7. PubMed ID: 25377256
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reliability of molecular tumour markers in children with medulloblastoma--an example from clinical practice].
    Pfister S
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(7):511-3. PubMed ID: 21958611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell phagocytosis. Its occurrence in a patient with medulloblastoma.
    Youness E; Barlogie B; Ahearn M; Trujillo JM
    Arch Pathol Lab Med; 1980 Dec; 104(12):651-3. PubMed ID: 6893661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow relapse of medulloblastoma mimicking acute leukemia with translocation (1;18)(p33;q22).
    Lou Y; Meng H; Mao L; Jin J
    J Clin Oncol; 2011 Jan; 29(2):e24-6. PubMed ID: 20940187
    [No Abstract]   [Full Text] [Related]  

  • 5. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
    von Hoff K; Hartmann W; von Bueren AO; Gerber NU; Grotzer MA; Pietsch T; Rutkowski S
    Pediatr Blood Cancer; 2010 Mar; 54(3):369-76. PubMed ID: 19908297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medulloblastoma in two brothers.
    Yamashita Y; Handa H; Toyama M
    Surg Neurol; 1975 Aug; 4(2):225-7. PubMed ID: 1162594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinico-pathological description of three paediatric medulloblastoma cases with MLL2/3 gene mutations.
    López GY; Grant GA; Fuchs HE; Leithe LG; Gururangan S; Bigner DD; Yan H; McLendon RE; He Y
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):217-20. PubMed ID: 23659599
    [No Abstract]   [Full Text] [Related]  

  • 8. Large-cell medulloblastoma with arrestin-like protein expression.
    Vincent S; Mirshari M; Nicolas C; Adenis C; Dhellemmes P; Soto Ares G; Maurage CA; Baranzelli MC; Giangaspero F; Ruchoux MM
    Clin Neuropathol; 2003; 22(1):1-9. PubMed ID: 12617187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Aggressiveness of TP53-Wild Type Sonic Hedgehog Medulloblastoma With MYCN Amplification, Chromosome 17p Loss, and Chromothripsis.
    Mitani Y; Fukuoka K; Mori M; Arakawa Y; Matsushita Y; Hibiya Y; Honda S; Kobayashi M; Tanami Y; Kanemura Y; Ichimura K; Nakazawa A; Kurihara J; Koh K
    J Neuropathol Exp Neurol; 2021 Jan; 80(2):205-207. PubMed ID: 33367701
    [No Abstract]   [Full Text] [Related]  

  • 10. Hedgehogs, flies, Wnts and MYCs: the time has come for many things in medulloblastoma.
    Monje M; Beachy PA; Fisher PG
    J Clin Oncol; 2011 Apr; 29(11):1395-8. PubMed ID: 21357776
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.
    Rutkowski S; von Bueren A; von Hoff K; Hartmann W; Shalaby T; Deinlein F; Warmuth-Metz M; Soerensen N; Emser A; Bode U; Mittler U; Urban C; Benesch M; Kortmann RD; Schlegel PG; Kuehl J; Pietsch T; Grotzer M
    Clin Cancer Res; 2007 May; 13(9):2651-7. PubMed ID: 17473196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth.
    Hatton BA; Knoepfler PS; Kenney AM; Rowitch DH; de Alborán IM; Olson JM; Eisenman RN
    Cancer Res; 2006 Sep; 66(17):8655-61. PubMed ID: 16951180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
    Grotzer MA; von Hoff K; von Bueren AO; Shalaby T; Hartmann W; Warmuth-Metz M; Emser A; Kortmann RD; Kuehl J; Pietsch T; Rutkowski S
    Klin Padiatr; 2007; 219(6):312-7. PubMed ID: 18050040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medulloblastoma and spino-meningeal metastaszing. Differential diagnosis in the clinical picture and pathologic anatomy. A case contribution].
    Thörner G; Schuier F
    Nervenarzt; 1976 Jun; 47(6):392-7. PubMed ID: 958540
    [No Abstract]   [Full Text] [Related]  

  • 15. Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma.
    Zhou L; Picard D; Ra YS; Li M; Northcott PA; Hu Y; Stearns D; Hawkins C; Taylor MD; Rutka J; Der SD; Huang A
    Cancer Res; 2010 Oct; 70(20):8199-210. PubMed ID: 20876797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.
    Hill RM; Kuijper S; Lindsey JC; Petrie K; Schwalbe EC; Barker K; Boult JK; Williamson D; Ahmad Z; Hallsworth A; Ryan SL; Poon E; Robinson SP; Ruddle R; Raynaud FI; Howell L; Kwok C; Joshi A; Nicholson SL; Crosier S; Ellison DW; Wharton SB; Robson K; Michalski A; Hargrave D; Jacques TS; Pizer B; Bailey S; Swartling FJ; Weiss WA; Chesler L; Clifford SC
    Cancer Cell; 2015 Jan; 27(1):72-84. PubMed ID: 25533335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
    Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
    J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 Mutation, MYCN Amplification, and Large Cell/Anaplastic Histology in Medulloblastoma.
    Das A; Zameer L; Vinarkar S; Singh M; Parihar M; Arora N; Chandra A; Achari RB
    Indian J Pediatr; 2018 Aug; 85(8):684-685. PubMed ID: 29139064
    [No Abstract]   [Full Text] [Related]  

  • 19. c-myc overexpression causes anaplasia in medulloblastoma.
    Stearns D; Chaudhry A; Abel TW; Burger PC; Dang CV; Eberhart CG
    Cancer Res; 2006 Jan; 66(2):673-81. PubMed ID: 16423996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated c-myc expression in childhood medulloblastomas.
    MacGregor DN; Ziff EB
    Pediatr Res; 1990 Jul; 28(1):63-8. PubMed ID: 2198527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.